Medium materiality5/10
Incyte price target raised to $120 from $107 at Oppenheimer
Why it may matterVerify against the original reporting
Target downgrade implying potential downside.
Public signal · 1-minute delayed
Signal brief
Source-backed market context you can read and share without an account.
AI summary
What happened, with direct paths to the underlying reporting
Oppenheimer raises Incyte target to $120 from $107; current price $130.08.
- Target up to $120; price $130.08.
Key facts
- 01
Target: $120
- 02
Posted price: $130.08
- 03
Analyst firm: Oppenheimer
How to read this signal
Transparent limits for an AI-generated research aid
StockNews.AI groups source reporting, classifies the event, and measures subsequent price movement. This is informational research, not investment advice. Prices may be delayed or unavailable.